Pharmaceutical Technology | Drug Development News & Views …
Pharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.
Artificial Intelligence in Pharma: Innovations, Patents, and Trends
Aug 20, 2024 · Pharmaceutical companies are increasingly harnessing artificial intelligence (AI) to advance research and development, resulting in groundbreaking healthcare solutions. Recent innovations include AI-driven cancer treatment target identification, optimized drug combinations, and automated systems for improved production efficiency and sterility ...
Pharma breakthroughs: 10 novel drug approvals that made …
Dec 20, 2023 · Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023 Pharmaceutical Technology outlines some of the biggest US Food and Drug Administration (FDA) drug approvals announced in 2023 that are set to make an impact in the coming years.
The top emerging pharmaceutical companies in the US
Mar 26, 2024 · Beam Therapeutics – $377.7m. 10. Denali Therapeutics – $330.5m. 1. Organon & Co- $6.26bn. Organon & Co (Organon) is the leading emerging pharmaceutical company in the US in 2023, reaching $6.26bn in annual revenues. The FY 2023 revenue of $6.26bn was 1% higher than the previous year and by 3% at constant currencies.
Pharma Technology Focus Magazine - Pharmaceutical Technology
In this issue: Developing drugs for metabolic disorders, solving the drug delivery conundrum for Alzheimer's disease drugs, and the growth of artificial intelligence (AI) in healthcare, and more. Whether you want to increase brand awareness, deliver a complex message or launch a new product, our online magazine provides a creative medium to ...
Top 20 biopharmaceutical companies hold their spot despite …
May 3, 2022 · Johnson & Johnson maintained its top position, with its market cap for Q1 2022 growing by 3.5% from $450.4 billion to $466.0 billion as of March 31, 2022.
Pharma developments in 2022: what you need to know
Jan 5, 2022 · The Covid-19 pandemic significantly altered the clinical trials landscape, and a Clinical Trials Arena analysis by Andrew and Kezia Parkins shows the frequency of decentralised clinical trials will reach new heights in 2022, with a 28% jump from last year.. Looking at the bigger picture, Andrew reports that middle-income countries’ healthcare sectors are expected to …
Magazine: Cell and gene therapy approvals drive paradigm …
Oct 8, 2024 · Magazine: Cell and gene therapy approvals drive paradigm change in manufacturing. In this issue: The manufacturing shift to meet growing cell and gene therapy demand, applying lessons from the Covid-19 pandemic to address mpox, a ten-year review of Opdivo and Keytruda, and more.
AstraZeneca, Gilead merger would be the biggest in the pharma …
Jun 11, 2020 · The Speculation Around an AstraZeneca-Gilead Merger. AstraZeneca, the UK’s largest drugmaker valued at $140bn, has reportedly contacted Gilead Sciences, an American biopharmaceutical company with a market value of approximately $96bn, regarding a possible merger deal. The approach was supposedly informal and aimed at testing its US rivals ...
Latest News - Pharmaceutical Technology
Latest News - Pharmaceutical Technology. Amgen reports 45.9% decline in net income to $746m in Q2 2024. Q2 2024 update: electronic medical record (emr) systems related private equity activity in the pharmaceutical industry. Transforming pharmaceutical R&D: the impact of digital technologies on drug discovery and development.